Managers / Q1 2019 · view latest →

KNOTT DAVID M

CIK 0000808722

Reported Value

$251M

Q1 2019

Positions

143

Filings on Record

2019–present window

Filed

May 13, 2019

original filing

Summary

Knott David M reported $251M in U.S.-listed holdings across 143 positions for Q1 2019.

Its largest position, LGND, represents 17.1% of the portfolio.

Compared with Q4 2018, the fund opened 14 new positions and exited 5.

Portfolio Metrics

Turnover

+9.6%

vs prior filed quarter

Top-10 Concentration

+55.9%

share of reported value

Largest Position

+17.1%

Ligand Pharmaceuticals Incorporated

New / Exited

14 / 5

positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value

Portfolio Composition

By security type

Common Stock · 77.0% · $193M
Other · 8.3% · $21M
MLP · 7.1% · $18M
Ltd Part · 5.1% · $13M
REIT · 1.8% · $4M
Other · 0.7% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2018 (amended baseline)

Issuer	Move	Share Δ	Shares now	Value Δ	Value now
SRCLEUR Stericycle, Inc.	NEW	+224.1K	224.1K	+$12M	$12M
GOOG Alphabet Inc-Cl C	NEW	+7.0K	7.0K	+$8M	$8M
International Gaming Technologies	NEW	+115.0K	115.0K	+$1M	$1M
BIIB Biogen Inc.	NEW	+2.5K	2.5K	+$590,000	$590,000
CELG Celgene Corporation	NEW	+5.0K	5.0K	+$469,000	$469,000
AUPH Aurinia Pharmaceuticals Inc.	NEW	+52.7K	52.7K	+$343,000	$343,000
NVSN Novartis AG	NEW	+3.0K	3.0K	+$288,000	$288,000
LXRX Lexicon Pharmaceuticals, Inc.	NEW	+30.0K	30.0K	+$167,000	$167,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2019

48 positions

Export to Excel

#	Issuer	Class	% Portfolio	Value ↓	Shares
1	LGND Ligand Pharmaceuticals Incorporated history →	Common	17.15%	$43M	342.2K
2	UPLDEUR Upland Software, Inc.history →	Common	7.40%	$19M	438.0K
3	FTAIEUR Fortress Trans & Infrastructure Inv. LLC history →	Common	5.12%	$13M	750.0K
4	SRCLEUR Stericycle, Inc.history →	Common	4.86%	$12M	224.1K
5	MPLX MPLX LP history →	Common	4.32%	$11M	329.6K
6	Apollo Global Management, LLC	Common	3.63%	$9M	322.7K
7	CFFN Capitol Federal Financial, Inc.history →	Common	3.52%	$9M	661.3K
8	LKQ1 LKQ Corporation history →	Common	3.39%	$9M	300.0K
9	AYAEUR The Star Group, Inc.history →	Common	3.29%	$8M	470.8K
10	GOOG Alphabet Inc-Cl C history →	Common	3.27%	$8M	7.0K
11	ORCL Oracle Corporation history →	Common	3.21%	$8M	150.0K
12	MIC2USD Macquarie Infrastructure Corporation history →	Common	2.69%	$7M	163.6K
13	PFE Pfizer Inc.history →	Common	2.45%	$6M	145.0K
14	Calumet Specialty Products Partners, LP	Common	2.18%	$5M	1.53M
15	LOW Lowe's Companies, Inc.history →	Common	1.96%	$5M	45.0K
16	AAPL Apple Inc.history →	Common	1.82%	$5M	24.0K
17	AOBCEUR American Outdoor Brands Corporation history →	Common	1.45%	$4M	390.0K
18	MIKUSD The Michaels Companies, Inc.history →	Common	1.37%	$3M	300.0K
19	IRDM Iridium Communications, Inc.history →	Common	1.19%	$3M	113.4K
20	DAL Delta Air Lines, Inc.history →	Common	1.18%	$3M	57.5K
21	HHC*The Howard Hughes Corporation history →	Common	1.14%	$3M	25.9K
22	CN2 Catalyst Pharmaceuticals, Inc.history →	Common	1.04%	$3M	510.8K
23	JPM JP Morgan & Chase	Common	0.93%	$2M	23.1K
24	VKTX Viking Therapeutics, Inc.	Common	0.86%	$2M	218.1K
25	CHCT Community Healthcare Trust Incorporated	Common	0.86%	$2M	60.0K
26	Intec Pharma Ltd.	Common	0.85%	$2M	290.4K
27	BioDelivery Sciences International, Inc.	Common	0.85%	$2M	400.5K
28	STMLEUR Stemline Therapeutics, Inc.	Common	0.81%	$2M	157.8K
29	CLDNEUR Eiger BioPharmaceuticals, Inc.	Common	0.73%	$2M	131.3K
30	XENE Xenon Pharmaceuticals Inc.	Common	0.73%	$2M	179.4K
31	DowDupont Inc.	Common	0.70%	$2M	33.2K
32	ARNAEUR Arena Pharmaceuticals, Inc.	Common	0.66%	$2M	36.7K
33	RDUSEUR Radius Health Inc.	Common	0.61%	$2M	77.3K
34	Quotient Limited	Common	0.61%	$2M	170.0K
35	International Gaming Technologies	Common	0.60%	$1M	115.0K
36	CXW CoreCivic, Inc.	Common	0.58%	$1M	75.0K
37	ZGNXEUR Zogenix, Inc.	Common	0.57%	$1M	26.0K
38	AB AllianceBernstein Holdings LP Unit Ltd	Common	0.56%	$1M	49.0K
39	Foamix Pharmaceuticals Ltd.	Common	0.52%	$1M	346.3K
40	Horizon Pharma Public Limited Company	Common	0.50%	$1M	47.8K
41	AIMT Aimmune Therapeutics, Inc.	Common	0.49%	$1M	55.1K
42	CNCEEUR Concert Pharmaceuticals, Inc.	Common	0.40%	$1M	83.6K
43	BAC Verizon Communications Inc.	Common	0.40%	$1M	17.0K
44	RHP Ryman Hospitality Ppty Inc.	Common	0.39%	$987,000	12.0K
45	Global Medical REIT, Inc. Ser A Cum Pfd.	Common	0.36%	$893,000	35.0K
46	XLRN Acceleron Pharma, Inc.	Common	0.32%	$810,000	17.4K
47	EPRT Essential Properties Realty Trust, Inc.	Common	0.31%	$781,000	40.0K
48	KMB Kimberly Clark Corporation	Common	0.30%	$743,000	6.0K

Filing History

Quarter	Reported Value	Positions	Filed	Type	Links
Q3 2021	$275M	197	Nov 12, 2021	13F-HR	changes · EDGAR ↗
Q2 2021	$281M	195	Aug 13, 2021	13F-HR	changes · EDGAR ↗
Q1 2021	$234M	166	May 13, 2021	13F-HR	changes · EDGAR ↗
Q4 2020	$221M	145	Feb 12, 2021	13F-HR	changes · EDGAR ↗
Q3 2020	$170M	135	Nov 13, 2020	13F-HR	changes · EDGAR ↗
Q2 2020	$183M	127	Aug 12, 2020	13F-HR	changes · EDGAR ↗
Q1 2020	$158M	156	May 13, 2020	13F-HR	changes · EDGAR ↗
Q4 2019	$247M	152	Feb 14, 2020	13F-HR	changes · EDGAR ↗
Q3 2019	$238M	157	Nov 12, 2019	13F-HR	changes · EDGAR ↗
Q2 2019	$237M	148	Aug 12, 2019	13F-HR	changes · EDGAR ↗
Q1 2019	$251M	143	May 13, 2019	13F-HR	changes · EDGAR ↗
Q4 2018	$213M	133	Feb 12, 2019	13F-HR	changes · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

DORSET MANAGEMENT CORP028-10281

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.